Nahoko Yata

1.0k total citations
21 papers, 663 citations indexed

About

Nahoko Yata is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Nahoko Yata has authored 21 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Nahoko Yata's work include Renal Diseases and Glomerulopathies (10 papers), Platelet Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Nahoko Yata is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Platelet Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Nahoko Yata collaborates with scholars based in Japan, United States and Sweden. Nahoko Yata's co-authors include Kazumoto Iijima, Koichi Nakanishi, Kenji Ishikura, Masataka Honda, Norishige Yoshikawa, Satoshi Sasaki, Takeshi Matsuyama, Koh Okamoto, Yoko Nukui and Shuji Hatakeyama and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Nahoko Yata

20 papers receiving 633 citations

Peers

Nahoko Yata
Bruce A. Kaiser United States
Elliott Savdie Australia
Jolene Kay Berg United States
Natalie Finch United Kingdom
Nahoko Yata
Citations per year, relative to Nahoko Yata Nahoko Yata (= 1×) peers Oluwatoyin F. Bamgbola

Countries citing papers authored by Nahoko Yata

Since Specialization
Citations

This map shows the geographic impact of Nahoko Yata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahoko Yata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahoko Yata more than expected).

Fields of papers citing papers by Nahoko Yata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahoko Yata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahoko Yata. The network helps show where Nahoko Yata may publish in the future.

Co-authorship network of co-authors of Nahoko Yata

This figure shows the co-authorship network connecting the top 25 collaborators of Nahoko Yata. A scholar is included among the top collaborators of Nahoko Yata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahoko Yata. Nahoko Yata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishikura, Kenji, Norishige Yoshikawa, Hitoshi Nakazato, et al.. (2014). Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatric Nephrology. 30(3). 459–468. 42 indexed citations
2.
Iijima, Kazumoto, Mayumi Sako, Mari S. Oba, et al.. (2013). Cyclosporine C2 Monitoring for the Treatment of Frequently Relapsing Nephrotic Syndrome in Children. Clinical Journal of the American Society of Nephrology. 9(2). 271–278. 18 indexed citations
3.
Yata, Nahoko, Osamu Uemura, Masataka Honda, et al.. (2013). Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays. Clinical and Experimental Nephrology. 17(6). 872–876. 14 indexed citations
4.
Nukui, Yoko, Shuji Hatakeyama, Koh Okamoto, et al.. (2013). High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. Journal of Antimicrobial Chemotherapy. 68(9). 2128–2133. 140 indexed citations
5.
Ikezumi, Yohei, Masataka Honda, Takeshi Matsuyama, et al.. (2012). Establishment of a normal reference value for serum β2 microglobulin in Japanese children: reevaluation of its clinical usefulness. Clinical and Experimental Nephrology. 17(1). 99–105. 11 indexed citations
6.
Ishikura, Kenji, Norishige Yoshikawa, Hitoshi Nakazato, et al.. (2012). Two-Year Follow-Up of a Prospective Clinical Trial of Cyclosporine for Frequently Relapsing Nephrotic Syndrome in Children. Clinical Journal of the American Society of Nephrology. 7(10). 1576–1583. 21 indexed citations
7.
Hatakeyama, Shuji, Kiyoko Iwatsuki‐Horimoto, Koh Okamoto, et al.. (2011). Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults. Vaccine. 29(49). 9224–9228. 12 indexed citations
8.
Uemura, Osamu, Masataka Honda, Takeshi Matsuyama, et al.. (2011). Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clinical and Experimental Nephrology. 15(5). 694–699. 78 indexed citations
9.
Ishikura, Kenji, N. Yoshikawa, S Hattori, et al.. (2010). Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome. Nephrology Dialysis Transplantation. 25(12). 3956–3962. 34 indexed citations
10.
Hamasaki, Yuko, Norishige Yoshikawa, Shinzaburo Hattori, et al.. (2009). Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatric Nephrology. 24(11). 2177–2185. 56 indexed citations
11.
Yata, Nahoko, Koichi Nakanishi, Yuko Shima, et al.. (2008). Improved renal survival in Japanese children with IgA nephropathy. Pediatric Nephrology. 23(6). 905–912. 36 indexed citations
12.
Ishikura, Kenji, Masato Ikeda, S Hattori, et al.. (2008). Effective and safe treatment with cyclosporine in nephrotic children: A prospective, randomized multicenter trial. Kidney International. 73(10). 1167–1173. 63 indexed citations
13.
Nakanishi, Koichi, Mayumi Sako, Nahoko Yata, et al.. (2006). Segmental Membranous Glomerulonephritis in Children. Clinical Journal of the American Society of Nephrology. 1(4). 723–729. 21 indexed citations
14.
Sako, Mayumi, Koichi Nakanishi, Nahoko Yata, et al.. (2005). Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney International. 67(4). 1248–1255. 61 indexed citations
15.
Yata, Nahoko, Masahiro Ikeda, Kenji Ishikura, et al.. (2004). Typical MPGN with few urinary abnormalities. American Journal of Kidney Diseases. 43(5). 918–922. 2 indexed citations
16.
Yata, Nahoko, Koichi Nakanishi, Shigeru Uemura, et al.. (2004). Evaluation of the inferior vena cava in potential pediatric renal transplant recipients. Pediatric Nephrology. 19(9). 1062–4. 15 indexed citations
17.
Yoshikawa, Norishige, Koichi Nakanishi, Mayumi Sako, et al.. (2004). A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy. Pediatric Nephrology. 19(2). 144–147. 17 indexed citations
18.
Yata, Nahoko, Kenji Ishikura, Hiroshi Hataya, Masahiro Ikeda, & Masataka Honda. (2003). [Peritoneal dialysis catheter-related complications].. PubMed. 45(4). 378–80.
19.
Sugihara, Narumi, K. Furuno, Nobuyuki Kita, Teruo Murakami, & Nahoko Yata. (1992). Plasma .ALPHA.1-Acid Glycoprotein Concentration in Rats with Chemical Liver Injury.. Chemical and Pharmaceutical Bulletin. 40(9). 2516–2519. 7 indexed citations
20.
Yata, Nahoko, Narumi Sugihara, Yukihito Higashi, et al.. (1986). Enhanced small intestinal absorption of .BETA.-lactam antibiotics in rats in the presence of monodesmosides isolated from pericarps of Sapindus mukurossi (enmei-hi).. Journal of Pharmacobio-Dynamics. 9(2). 211–217. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026